Chiesi Italia clinical trials
A country office of Chiesi Farmaceutici S.p.A.
The registry lists 5 studies whose lead sponsor is Chiesi Italia. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.
Registry sponsor names on this page
- Chiesi Italia5 studies
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Chiesi Farmaceutici S.p.A. studies →
- Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world SettingRecruitingNCT07109375
Sponsor listed in the registry: Chiesi Italia
- Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma ControlCompletedNCT05168995
Sponsor listed in the registry: Chiesi Italia
- Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world SettingCompletedNCT06100042
Sponsor listed in the registry: Chiesi Italia
- Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)CompletedNCT03963167
Sponsor listed in the registry: Chiesi Italia
- Global Burden and Treatment Trajectiories in Italian Patients With Fabry DiseaseCompletedNCT04916977
Sponsor listed in the registry: Chiesi Italia